Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2025)
Historic Interest & Investment Income for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $306000.0.
- Aquestive Therapeutics' Interest & Investment Income fell 6874.36% to $306000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 3420.5%. This contributed to the annual value of $3.4 million for FY2024, which is 7894.12% down from last year.
- Aquestive Therapeutics' Interest & Investment Income amounted to $306000.0 in Q3 2025, which was down 6874.36% from $2.1 million recorded in Q2 2025.
- Aquestive Therapeutics' 5-year Interest & Investment Income high stood at $14.5 million for Q1 2023, and its period low was -$52000.0 during Q1 2021.
- In the last 5 years, Aquestive Therapeutics' Interest & Investment Income had a median value of $306000.0 in 2025 and averaged $1.2 million.
- As far as peak fluctuations go, Aquestive Therapeutics' Interest & Investment Income tumbled by 51250.0% in 2021, and later skyrocketed by 48386666.67% in 2023.
- Aquestive Therapeutics' Interest & Investment Income (Quarter) stood at $135000.0 in 2021, then plummeted by 51.85% to $65000.0 in 2022, then surged by 153.85% to $165000.0 in 2023, then surged by 344.85% to $734000.0 in 2024, then crashed by 58.31% to $306000.0 in 2025.
- Its Interest & Investment Income was $306000.0 in Q3 2025, compared to $2.1 million in Q2 2025 and $713000.0 in Q1 2025.